Alnylam Pharmaceuticals (ALNY) Stock Chart & Stock Price History $464.95 +4.49 (+0.98%) Closing price 10/13/2025 04:00 PM EasternExtended Trading$464.00 -0.95 (-0.20%) As of 10/13/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Alnylam Pharmaceuticals Stock Price Performance The Alnylam Pharmaceuticals (ALNY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 64.11%, with a year-to-date return of 97.59%. In the past month, the stock has decreased 0.20%, reflecting recent market activity. As of the latest close, Alnylam Pharmaceuticals traded at $464.95 with a market cap of $60.95 billion and volume of 1.58 million shares. Five years ago, the stock traded at $143.91, representing a 223.08% increase over that period. At the time, it had a market cap of $16.69 billion and a volume of 251,356 shares. Receive ALNY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+1.75%1 Month Performance-0.20%3 Month Performance+47.25%Year-To-Date Performance+97.59%1 Year Performance+64.11%5 Year Performance+223.08% ALNY Stock Chart for Tuesday, October, 14, 2025 ALNY Chart by TradingView Alnylam Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/13/2025$459.66$464.95+1.15%$473.65$453.831.58 million shs$60.95 billion10/10/2025$456.95$459.66+0.59%$460.60$451.00937,045 shs$60.25 billion10/09/2025$450.68$456.95+1.39%$459.57$448.831.05 million shs$59.90 billion10/08/2025$459.58$450.68-1.94%$464.46$449.72929,840 shs$59.08 billion10/07/2025$452.00$459.58+1.68%$462.63$448.95791,843 shs$60.24 billion10/06/2025$456.35$452.00-0.95%$458.69$449.92918,497 shs$59.25 billion10/03/2025$460.99$456.35-1.01%$465.01$448.47969,084 shs$59.82 billion10/02/2025$460.65$460.99+0.07%$461.53$446.181.27 million shs$60.43 billion10/01/2025$456.00$460.65+1.02%$467.42$453.311.37 million shs$60.38 billion09/30/2025$447.49$456.00+1.90%$459.30$445.221.38 million shs$59.77 billion Get the Latest News and Ratings for ALNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/29/2025$446.40$447.49+0.24%$451.63$446.30719,040 shs$58.66 billion09/26/2025$449.58$446.40-0.71%$453.05$442.51812,980 shs$58.51 billion09/25/2025$458.37$449.58-1.92%$459.00$446.42685,313 shs$58.93 billion09/24/2025$454.41$458.37+0.87%$462.69$450.97975,990 shs$60.08 billion09/23/2025$458.92$454.41-0.98%$457.47$450.501.02 million shs$59.56 billion09/22/2025$453.56$458.92+1.18%$462.88$450.23971,754 shs$60.15 billion09/19/2025$452.17$453.56+0.31%$457.68$450.721.71 million shs$59.45 billion09/18/2025$451.73$452.17+0.10%$456.94$443.751.06 million shs$59.27 billion09/17/2025$461.24$451.73-2.06%$463.88$450.701.45 million shs$59.21 billion09/16/2025$461.14$461.24+0.02%$467.28$457.99773,322 shs$60.46 billion09/15/2025$465.89$461.14-1.02%$466.24$454.51910,054 shs$60.45 billion Related Companies Amgen Stock Price Chart Gilead Sciences Stock Price Chart Vertex Pharmaceuticals Stock Price Chart Regeneron Pharmaceuticals Stock Price Chart Biogen Stock Price Chart United Therapeutics Stock Price Chart Incyte Stock Price Chart Neurocrine Biosciences Stock Price Chart Ionis Pharmaceuticals Stock Price Chart Exact Sciences Stock Price Chart Receive ALNY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALNY) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
